Cas:881214-42-2 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride manufacturer & supplier

Chemical Name:1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride

CAS.NO:881214-42-2

Synonyms:1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride

Molecular Formula:C₁₁H₂₂Cl₄N₄

Molecular Weight:352.13118

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride Use and application,1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride technical grade,usp/ep/jp grade.

Related News: At ASH, scientists from the Company and MSK presented new in vivo preclinical data demonstrating that FT819 exhibits durable tumor control and extended survival. 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride manufacturer As Reuters reported last month, Lilly tapped the Washington D.C. law firm Covington & Burling LLP to investigate the alleged alterations, which the employees said were meant to downplay serious quality control problems at the plant producing the drugmaker’s COVID-19 antibody treatment. 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride supplier The United States has suspended imports of dogs from more than 100 countries where there’s a high rabies risk. 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride vendor Rigosertib, Onconova��s lead candidate, is a proprietary Phase 3 small molecule. 1,2-Benzenediamine, 4-(4-methyl-1-piperazinyl)-, tetrahydrochloride factory The survival benefit is “unprecedented” for an aging myeloma population, almost all of whom were 65 years of age or older, said Craig Tendler, M.D., vice president of oncology clinical development and global medical affairs at J&J’s Janssen unit, during an interview.